Overview Tricaprilin Infantile Spasms Pilot Study Status: Recruiting Trial end date: 2022-08-01 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety, tolerability, and efficacy of tricaprilin in subjects with infantile spasms. This is a single-arm, open-label, pilot study in up to 10 subjects with infantile spasms. Phase: Phase 1 Details Lead Sponsor: Cerecin